A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation

BACKGROUND: New-onset diabetes mellitus after transplantation (NODAT), a frequent and serious complication after transplantation, is associated with decreased graft and patient survival. Currently, it is diagnosed and treated primarily according to existing guidelines for type II diabetes. To date,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Haidinger, Michael, Werzowa, Johannes, Voigt, Hans-Christian, Pleiner, Johannes, Stemer, Gunar, Hecking, Manfred, Döller, Dominik, Hörl, Walter H, Weichhart, Thomas, Säemann, Marcus D
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2984585/
https://ncbi.nlm.nih.gov/pubmed/20925938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-11-91
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados